These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Dermatitis herpetiformis]. Teillac D Ann Dermatol Venereol; 1989; 116(8):571-4. PubMed ID: 2688517 [No Abstract] [Full Text] [Related]
4. Serum complement (C'3) and immunoglobulin levels in dermatitis herpetiformis. Fraser NG; Beck JS; Albert-Recht F Br J Dermatol; 1971 Oct; 85(4):314-9. PubMed ID: 5125636 [No Abstract] [Full Text] [Related]
5. Dermatitis herpetiformis: effect of gluten-restricted and gluten-free diet on dapsone requirement and on IgA and C3 deposits in uninvolved skin. Ljunghall K; Tjernlund U Acta Derm Venereol; 1983; 63(2):129-36. PubMed ID: 6189327 [No Abstract] [Full Text] [Related]
6. Effects of dapsone and gluten-free diet on the immune complexes in the skin of patients with dermatitis herpetiformis [proceedings]. van der Meer JB; Poen H; van der Putte SC; Nefkens MJ; Baart de la Faille-Kuyper EH Br J Dermatol; 1979 Aug; 101(2):232-3. PubMed ID: 486336 [No Abstract] [Full Text] [Related]
7. The treatment of dermatitis herpetiformis. Fry L Clin Exp Dermatol; 1982 Nov; 7(6):633-42. PubMed ID: 6758995 [No Abstract] [Full Text] [Related]
9. Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Moi H Acta Derm Venereol; 1984; 64(2):144-50. PubMed ID: 6203303 [TBL] [Abstract][Full Text] [Related]
10. Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Seah PP; Fry L; Mazaheri MR; Mowbray JF; Hoffbrand AV; Holborow EJ Lancet; 1973 Jul; 2(7822):175-7. PubMed ID: 4124252 [No Abstract] [Full Text] [Related]
12. [Duhring's dermatitis herpetiformis]. Fries P Z Hautkr; 1985 Mar; 60(6):489-90, 495-6. PubMed ID: 3887785 [TBL] [Abstract][Full Text] [Related]
13. Dermatitis herpetiformis with linear IgA deposition: ultrastructural localization of in vivo bound IgA. Yamasaki Y; Hashimoto T; Nishikawa T Acta Derm Venereol; 1982; 62(5):401-5. PubMed ID: 6183889 [TBL] [Abstract][Full Text] [Related]
15. Treatment and management of dermatitis herpetiformis. Leonard JN; Fry L Clin Dermatol; 1991; 9(3):403-8. PubMed ID: 1806228 [No Abstract] [Full Text] [Related]
16. Dermatitis herpetiformis. The role of gluten. Marks J; Shuster S Arch Dermatol; 1970 Apr; 101(4):452-7. PubMed ID: 5443952 [No Abstract] [Full Text] [Related]
17. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis. Sanders SW; Zone JJ Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the activation of complement via the alternate pathway in skin diseases. II. Dermatitis herpetiformis. Provost TT; Tomasi TB Clin Immunol Immunopathol; 1974 Nov; 3(2):178-86. PubMed ID: 4217677 [No Abstract] [Full Text] [Related]
19. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Fry L; Seah PP; Riches DJ; Hoffbrand AV Lancet; 1973 Feb; 1(7798):288-91. PubMed ID: 4119171 [No Abstract] [Full Text] [Related]
20. Comparison of immunoglobulin and complement deposition in multiple biopsies from the uninvolved skin in dermatitis herpetiformis. Haffenden G; Wojnarowska F; Fry L Br J Dermatol; 1979 Jul; 101(1):39-45. PubMed ID: 475985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]